Interesting academic highlights article discussing the FDAs pregnancy and lactation labelling rule

Pregnancy labelling of medications is a hotly debated issue in the field of teratology, and several studies have shown the limitations of providing pregnancy safety category ratings for medicines. In this recent academic highlights article, the authors summarise discussions which were held at an April 2017 meeting focussed on pregnancy pharmacogivilance and the FDAs pregnancy and lactation labelling rule. Further […]

» Read more

Developmental toxicity risks of medicines included on the WHO’s Essential Medicines List

A collaboration of researchers from the University of Washington School of Medicine and the Washington Center for Epidemiology and Environmental Health have published their findings of a review into the developmental toxicity risks for medicines included on the WHO’s Essential Medicines List. The authors described a large proportion of these medicines had limited data concerning developmental risks, identifying a clear need […]

» Read more

Meta-analysis of malformation risk following maternal ondansetron use in pregnancy

A collaboration between ENTIS researchers from Izmir Katip Celebi University Teratology Information Center, the UK Teratology Information Service and Mothersafe at The Royal Hospital for Women, Sydney, Australia have published a meta-analysis of malformation risks following maternal first-trimester ondansetron use. More information is available here.   Photo by on Unsplash

» Read more
1 2 3